Formulation and Delivery
Blaine Bueche, PhD
R&D Principal Scientist
Kindeva Drug Delivery
Woodbury, Minnesota
Description: High Payload inhalation drug products in nebulizers and DPI’s are becoming more commonplace because the devices work well to solve the requirements of large liquid volume and high drug mass delivered to a patient’s lung. In addition, many of the new products are biologics which are often incompatible with standard aerosol apparatus and analytical methods. The USP guidelines have not been updated to address issues with high payload inhalation drug products.